PRINCETON, N.J., May 22, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of therapeutic dermatology, announced that it will package its seborrheic dermatitis treatment Xolegel(r) (ketoconazole, USP)...
[read full story]
PRINCETON, N.J., May 22, 2008 (PRIME NEWSWIRE) -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a pharmaceutical company developing and commercializing products in the field of therapeutic dermatology, announced that it will package its seborrheic dermatitis treatment Xolegel(r) (ketoconazole, USP)...
Thursday May 22, 7:30 am ET Latest Offering for Seborrheic Dermatitis of Face, Body and Scalp Soon to be Marketed and Sold by Barrier Therapeutics PRINCETON, N.J., May 22, 2008 (PRIME NEWSWIRE) -- News), a pharmaceutical company developing and commercializing products in the field of therapeutic...
Thursday May 22, 8:20 am ET Barrier Therapeutics, Procter & Gamble sign deal to sell shampoo and skin gel together PRINCETON, N.J. (AP) -- Dermatology products maker Barrier Therapeutics Inc. on Thursday said it signed a deal to sell its dermatitis treatment Xolegel together with Procter &...
PRINCETON, N.J. (AP) - Dermatology products maker Barrier Therapeutics Inc. on Thursday said it signed a deal to sell its dermatitis treatment Xolegel together with Procter & Gamble's dandruff shampoo Head & Shoulders. The kit, known as Xolegel Duo, is expected to be available by prescription in...
Business Courier of Cincinnati have signed a deal to combine P&G's Head & Shoulders shampoo in a kit with Barrier's Xolegel dermatitis treatment. The kit will be available by prescription beginning in June, according to an Associated Press story. Barrier will manufacture and sell the kits, to be...